Bionano Genomics, Inc. (Nasdaq: BNGO) today announced Bionano Symposium 2026, the premier global event for the optical genome mapping (OGM) community. This virtual symposium provides a unique platform ...

OGM was selected as a genome-wide, unbiased method to detect large genomic rearrangements and structural variants (SVs) with sensitivity to variant allele fractions (VAFs) as low as 5% to analyze ...

Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better ...

Holmlin reiterated, "We are reiterating our full year 2025 revenue guidance of $26 million to $30 million. We expect the fourth quarter of 2025 revenues to be in the range of $7.5 million to $7.9 ...

Bionano Genomics, which has commercialized a genome analysis platform used in laboratories across the world, is acquiring software firm BioDiscovery in a $90 million deal intended to broaden the reach ...

Holmlin provided updated full-year 2025 revenue guidance, stating "we expect full year revenues to be in the range of $26 million to $30 million which is an update compared to our previous views on ...

26 different customers representing North America, Asia and Europe 33 oral presentations across four consecutive days 69 scientific posters will be featured in a virtual exhibition hall Topics span ...

Hard-hit biotech stocks rallied during the first month of 2023. This cohort of equities, however, couldn't sustain their momentum this week. What's behind this sudden trend reversal? From a macro ...

Life sciences equipment manufacturer Bionano Genomics (NASDAQ:BNGO) was a popular meme stock last year. Consequently, its management raised a massive amount of cash through equity offerings. However, ...